Zobrazeno 1 - 9
of 9
pro vyhledávání: '"андрогенная алопеция"'
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 0, Iss 1, Pp 32-46 (2017)
Scope. To determine the therapeutic potency of telogen effluvium complex therapy and androgenetic alopecia. Materials and methods. There are presented results on treatment of 45 patients with telogen hair loss (15 women) and androgenetic alopecia (15
Externí odkaz:
https://doaj.org/article/5285108fe6254904a66c300b7a599cc8
Autor:
I. N. Kondrakhina, A. N. Mareeva
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 0, Iss 1, Pp 41-45 (2017)
The article describes the literature sources related to the efficacy of systemic therapy of androgenic alopecia in female and male.
Externí odkaz:
https://doaj.org/article/8dd0b1d83f7a4219be301c956ef9ffe6
Autor:
I. N. Kondrachine, A. N. Mareeva
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 0, Iss 5, Pp 81-85 (2017)
Literary and own data on trichoskopy opportunities are presented with differential-diagnostic tools of non-cicatricial alopecia. Clinical data are discussed, the importance of a trichoskopy is established at diagnosis of patients with alopecia of dif
Externí odkaz:
https://doaj.org/article/c06ce71f75a44747bacfe13b49727894
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 42-48 (2015)
Due to the associated serious endocrine and metabolic disorders, hyperandrogenic conditions result in skin lesions and deterioration of the quality of life. The present study aimed to evaluate androgen-dependent dermopathy in patients with various cl
Externí odkaz:
https://doaj.org/article/01c36f85d6704018b82f1de732f3ecf9
Publikováno v:
ScienceRise: Pharmaceutical Science; No. 6 (34) (2021); 27-36
ScienceRise: Pharmaceutical Science; № 6 (34) (2021); 27-36
ScienceRise: Pharmaceutical Science; № 6 (34) (2021); 27-36
Due to the content of phytosterols, extractive preparations of Urtica dioica roots are able to show antiandrogenic effect in the case of external therapy of men and women with androgenic alopecia. Oil extracts (OE) are characterized by several advant
Publikováno v:
Ukraïns’kij bìofarmacevtičnij žurnal; № 2(59) (2019); 50-54
Украинский биофармацевтический журнал; № 2(59) (2019); 50-54
Український біофармацевтичний журнал; № 2(59) (2019); 50-54
Украинский биофармацевтический журнал; № 2(59) (2019); 50-54
Український біофармацевтичний журнал; № 2(59) (2019); 50-54
Актуальність. Андрогенна алопеція (АА) – прогресуюче облисіння, викликане впливом андрогенів на волосяний фолікул (ВФ), що розвивається
Publikováno v:
Управління, економіка та забезпечення якості в фармації; № 1(61) (2020); 14-21
Management, economy and quality assurance in pharmacy; № 1(61) (2020); 14-21
Управление, экономика и обеспечение качества в фармации; № 1(61) (2020); 14-21
Management, economy and quality assurance in pharmacy; № 1(61) (2020); 14-21
Управление, экономика и обеспечение качества в фармации; № 1(61) (2020); 14-21
The required step in the new drug development is standardization of the finished product. The quality of dosage forms with soft medium depends on many factors. Taking into account the abovestated, for the developed “Flavosterol” emulgel it is imp
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 0, Iss 1, Pp 32-46 (2017)
Scope. To determine the therapeutic potency of telogen effluvium complex therapy and androgenetic alopecia. Materials and methods. There are presented results on treatment of 45 patients with telogen hair loss (15 women) and androgenetic alopecia (15
Autor:
A. N. Mareeva, I. N. Kondrakhina
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 0, Iss 1, Pp 41-45 (2017)
The article describes the literature sources related to the efficacy of systemic therapy of androgenic alopecia in female and male.